Mindray Medical Announces Participation in Upcoming Investor Conferences

SHENZHEN, China, Nov. 8, 2010 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will participate in the following conferences:

• Morgan Stanley Ninth Annual Asia Pacific Summit, to be held November 9-11, 2010 at the Mandarin Oriental in Singapore. Participants from Mindray will be Mr. Xiting Li, President and Co-CEO and Ms. May Li, Director and Head of Investor Relations. Management is scheduled to present at 2:15 pm on Thursday, November 11, and will meet with investors throughout the day.
• 2010 Credit Suisse Asian Healthcare Conference, to be held November 16-17, 2010 at the Conrad Hotel in Hong Kong. The conference will be attended by Ms. May Li, Director and Head of Investor Relations of Mindray. Ms. Li is scheduled to present at 9:00 am on Tuesday, November 16 and will meet with investors throughout the two-day conference.
• Daiwa Investment Conference (Hong Kong), to be held November 16-19, 2010 at the Island Shangri-La in Hong Kong. The conference will be attended by Ms. May Li, Director and Head of Investor Relations of Mindray. Ms. Li will meet with investors on November 19.
• Piper Jaffray 22nd Annual Healthcare Conference, to be held November 30 - December 1, 2010 at the New York Palace Hotel in New York. The conference will be attended by Mr. Ronald Ede, Chief Financial Officer of Mindray. Mr. Ede is scheduled to present at 8:30 am EST on Tuesday, November 30 and will meet with investors throughout the morning.

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://www.mindray.com.

SOURCE Mindray Medical International Limited